Best for
Mobile
How to buy Anthem shares | $311.4
Own Anthem shares in just a few minutes. Share price changes are updated daily.
Fact checked
Anthem, Inc (ANTM) is a leading healthcare plans business based in the US. It opened the day at $312.16 after a previous close of $313.75. During the day the price has varied from a low of $310.16 to a high of $315.91. The latest price was $311.4 (25 minute delay). Anthem is listed on the NYSE and employs 70,600 staff. All prices are listed in US Dollars.
How to buy shares in Anthem
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ANTM in this case.
- Research Anthem shares. The platform should provide the latest information available.
- Buy your Anthem shares. It's that simple.
What's in this guide?
- Can I buy shares in Anthem?
- Has coronavirus impacted Anthem shares?
- Anthem shares summary
- Compare share dealing platforms
- Is Anthem stock a buy or sell?
- Anthem performance over time
- Can I short Anthem shares?
- Is Anthem suitable for ethical investing?
- Are Anthem shares over-valued?
- Anthem's financials
- How volatile are Anthem shares?
- Does Anthem pay a dividend?
- Have Anthem shares ever split?
- Other common questions
How has Coronavirus impacted Anthem's share price?
Since the stock market crash in March caused by coronavirus, Anthem's share price has had significant negative movement.
Its last market close was $292.21, which is 0.85% down on its pre-crash value of $294.71 and 70.85% up on the lowest point reached during the March crash when the shares fell as low as $171.03.
If you had bought $1,000 worth of Anthem shares at the start of February 2020, those shares would have been worth $655.05 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,095.79.
Anthem share price
Use our graph to track the performance of ANTM stocks over time.Anthem shares at a glance
Information last updated 2020-12-11.
| Open | $312.16 |
|---|---|
| High | $315.91 |
| Low | $310.16 |
| Close | $311.4 |
| Previous close | $313.75 |
| Change | $-2.35 |
| Change % | -0.749% |
| Volume | 806,046 |
Information last updated 2020-12-27.
| 52-week range | $169.3836 - $337.2053 |
|---|---|
| 50-day moving average | $316.5206 |
| 200-day moving average | $284.7148 |
| Wall St. target price | $360.13 |
| PE ratio | 15.9388 |
| Dividend yield | $3.8 (1.23%) |
| Earnings per share (TTM) | $19.366 |
Invest in Anthem shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Anthem stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Anthem price performance over time
Historical closes compared with the last close of $311.4
| 1 week (2021-01-15) | -4.60% |
|---|---|
| 1 month (2020-12-22) | 2.67% |
| 3 months (2020-10-22) | 2.04% |
| 6 months (2020-07-22) | 16.16% |
| 1 year (2020-01-22) | 2.60% |
|---|---|
| 2 years (2019-01-22) | 17.70% |
| 3 years (2018-01-22) | 24.31% |
| 5 years (2016-01-22) | 120.23% |
Is Anthem under- or over-valued?
Valuing Anthem stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Anthem's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Anthem's P/E ratio
Anthem's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Anthem shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Anthem's P/E ratio is best considered in relation to those of others within the healthcare plans industry or those of similar companies.
- Hummingbird Resources (HUM.LSE): 3.86
- CVS Health Corporation (CVS.US): 12.44
- Cigna Corporation (CI.US): 13.96
- Centene Corporation (CNC.US): 15.38
Anthem's PEG ratio
Anthem's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0738. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Anthem's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Anthem's PEG ratio in relation to those of similar companies.
- CVS Health Corporation (CVS.US): 1.33
- Cigna Corporation (CI.US): 0.91
- Centene Corporation (CNC.US): 0.81
Anthem's EBITDA
Anthem's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $9.3 billion (£6.8 billion).
The EBITDA is a measure of a Anthem's overall financial performance and is widely used to measure a its profitability.
To put Anthem's EBITDA into context you can compare it against that of similar companies.
- Hummingbird Resources (HUM.LSE): £73.1 million
- CVS Health Corporation (CVS.US): USD$18.5 billion
- Cigna Corporation (CI.US): USD$11.3 billion
- Centene Corporation (CNC.US): USD$5.3 billion
Anthem financials
| Revenue TTM | $117.4 billion |
|---|---|
| Operating margin TTM | 7.45% |
| Gross profit TTM | $22.4 billion |
| Return on assets TTM | 6.65% |
| Return on equity TTM | 15.19% |
| Profit margin | 4.22% |
| Book value | $135.986 |
| Market capitalisation | $76.8 billion |
TTM: trailing 12 months
How to short and sell Anthem shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ANTM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 4.1 million Anthem shares held short by investors – that's known as Anthem's "short interest". This figure is 16.8% up from 3.5 million last month.
There are a few different ways that this level of interest in shorting Anthem shares can be evaluated.
Anthem's "short interest ratio" (SIR)
Anthem's "short interest ratio" (SIR) is the quantity of Anthem shares currently shorted divided by the average quantity of Anthem shares traded daily (recently around 1.3 million). Anthem's SIR currently stands at 3.25. In other words for every 100,000 Anthem shares traded daily on the market, roughly 3250 shares are currently held short.
To gain some more context, you can compare Anthem's short interest ratio against those of similar companies.
- CVS Health Corporation (CVS.US): 2.4
- Cigna Corporation (CI.US): 2.12
- Centene Corporation (CNC.US): 2.77
However Anthem's short interest can also be evaluated against the total number of Anthem shares, or, against the total number of tradable Anthem shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Anthem's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Anthem shares in existence, roughly 20 shares are currently held short) or 0.0165% of the tradable shares (for every 100,000 tradable Anthem shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Anthem.
Find out more about how you can short Anthem stock.
Anthem's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Anthem.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Anthem's total ESG risk score
Total ESG risk: 17.94
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Anthem's overall score of 17.94 (as at 01/01/2019) is excellent – landing it in it in the 13rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Anthem is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
To gain some more context, you can compare Anthem's total ESG risk score against those of similar companies.
- CVS Health Corporation (CVS.US): 18.73
- Cigna Corporation (CI.US): 13.57
- Centene Corporation (CNC.US): 28.72
Anthem's environmental score
Environmental score: 1.55/100
Anthem's environmental score of 1.55 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Anthem is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Anthem's social score
Social score: 10.27/100
Anthem's social score of 10.27 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Anthem is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Anthem's governance score
Governance score: 8.63/100
Anthem's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Anthem is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Anthem's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Anthem scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Anthem has, for the most part, managed to keep its nose clean.
Wondering how that compares? Below are the controversy scores of similar companies.
Environmental, social, and governance (ESG) summary
Anthem, Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 17.94 |
|---|---|
| Total ESG percentile | 12.86 |
| Environmental score | 1.55 |
| Environmental score percentile | 4 |
| Social score | 10.27 |
| Social score percentile | 4 |
| Governance score | 8.63 |
| Governance score percentile | 4 |
| Level of controversy | 2 |
Anthem share dividends
Dividend payout ratio: 15.99% of net profits
Recently Anthem has paid out, on average, around 15.99% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Anthem shareholders could enjoy a 1.23% return on their shares, in the form of dividend payments. In Anthem's case, that would currently equate to about $3.8 per share.
While Anthem's payout ratio might seem low, this can signify that Anthem is investing more in its future growth.
Anthem's most recent dividend payout was on 22 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 4 December 2020 (the "ex-dividend date").
Anthem's dividend payout ratio is perhaps best considered in relation to those of similar companies.
- Hummingbird Resources (HUM.LSE): 0.00% (does not pay dividend)
- CVS Health Corporation (CVS.US): 25.19%
- Cigna Corporation (CI.US): 0.21%
- Centene Corporation (CNC.US): 0.00% (does not pay dividend)
Have Anthem's shares ever split?
Anthem's shares were split on a 2:1 basis on 1 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Anthem shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Anthem shares which in turn could have impacted Anthem's share price.
Anthem share price volatility
Over the last 12 months, Anthem's shares have ranged in value from as little as $169.3836 up to $337.2053. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Anthem's is 0.9927. This would suggest that Anthem's shares are less volatile than average (for this exchange).
To put Anthem's beta into context you can compare it against those of similar companies.
- Hummingbird Resources (HUM.LSE): 0.5127
- CVS Health Corporation (CVS.US): 0.8072
- Cigna Corporation (CI.US): 0.8609
- Centene Corporation (CNC.US): 0.527
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Anthem overview
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2019, it served 41 million medical members through its affiliated health plans. Anthem, Inc. has a strategic relationship with Quest Diagnostics Incorporated to develop various outcomes-based programs for enhanced health care experience for consumers and providers. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Frequently asked questions
More guides on Finder
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert